Published on: 14 February 2020 China National Medical Products Administration grants approval of Roche’s Tecentriq in combination with chemotherapy as first-line treatment of people with extensive-stage small cell lung cancer more
Published on: 11 February 2020 Reminder: Invitation to Roche’s Virtual Early Drug Development gRED Event 2020 more
Published on: 10 February 2020 Roche provides topline results from investigator-led Phase II/III trial with gantenerumab in rare inherited form of Alzheimer’s disease more
18February Roche’s Virtual Early Drug Development gRED Event 2020 (GMT) Basel, Switzerland more add to calendar
Latest annual report Annual Report 2019 Highlights How medicines are making an impact in the lives of patients more Annual Report 19 Finance Report 19 Roche in Brief 19
